724 organization(s) found
Kymera
Kymera is a clinical-stage biotechnology company working to reinvent the treatment of human disease through the development of innovative, highly differentiated medicines that address critical health problems and dramatically improve patients’ lives. We are committed to advancing novel technologies, such as targeted protein degradation, to address previously undrugged disease-causing proteins that have escaped existing modalities, challenging conventional treatment paradigms to deliver a new generation of medicines in a disease-agnostic manner.
LALCEC
In Spanish: "En LALCEC, abordamos el cáncer de forma integral, poniendo énfasis tanto en la concientización y la detección temprana, como así también en el acompañamiento al paciente con cáncer, su familia y entorno afectivo."
LAOSA (Lymphoedema Association of South Africa)
Organisation promoting quality lymphoedema management and education, relevant for cancer-related lymphedema care and rehabilitation.
Letsee Imaging
Letsee Imaging is developing advanced imaging solutions, to provide every woman & man access to early and most accurate breast cancer detection. We are convinced that our technology will be the next gold reference in mammography.
Liga Contra el Cáncer - Peru
In Spanish: "Somos la primera institución, en el Perú, en realizar acciones de prevención y detección temprana de cáncer. Desde nuestra fundación, en el año 1950, hemos contribuido a disminuir la alta incidencia de la enfermedad, a través de acciones de prevención como campañas informativas, educativas y despistajes preventivos que permiten lograr una cultura preventiva y hábitos de vida saludables."
LLS Canada
The Leukemia & Lymphoma Society of Canada is the largest registered charitable health agency dedicated to supporting the blood cancer community in Canada. Our focus has grown and now includes: Funding research from bench to bedside Rethinking how a person navigates their blood cancer experience Providing targeted blood cancer information Offering tools for psychological and emotional support Empowering Canadians to take charge of their blood cancer experience through practical support and advocacy
LMC France (Leucémie Myéloïde Chronique France)
In French: "L’association LMC France (Leucémie Myéloïde Chronique France) a pour objet de développer par tous moyens, toutes actions liées à la leucémie myéloïde chronique (LMC). Ainsi, LMC France a vocation à rassembler les patients et leurs proches afin de les aider dans leur lutte contre la maladie à travers la recherche, l’information et la formation."
LSF (Lalla Salma Foundation – Morocco)
Implements national plans for cancer prevention and treatment, including clinical best practices and research promotion.
Lyell
We are a clinical-stage company advancing next-generation CAR T-cell product candidates for patients with cancer. We are building an industry-leading pipeline based on our deep understanding of T-cell biology and its interaction with cancer.
MaaT Pharma
MaaT Pharma is a leading, late-stage clinical company focused on developing innovative gut microbiome-driven therapies to modulate the immune system and enhance cancer patient survival. Supported by a talented team committed to making a difference for patients worldwide, the Company was founded in 2014 and is based in Lyon, France. As a pioneer, MaaT Pharma is leading the way in bringing the first microbiome-driven immunomodulator in oncology.
Marengo Therapeutics
OUR MISSION: The right activation of the right immune cells to promote lifelong protection against cancer. OUR VISION: To create a world in which everyone�s immune system can defeat cancer.
MASCC (Multinational Association of Supportive Care in Cancer)
We are an international, interdisciplinary organization dedicated to the practice, education, and research of supportive care in cancer.
Massachusetts General Hospital
Mass General has the largest hospital based research program in the U.S. Guided by the needs of our patients, Mass General delivers care grounded in leading edge research, advanced treatment offerings and the latest clinical trials.